Since adenoviral replication depends on E1A activity as an inductor of S-phase entry, adenoviruses with partial deletions in E1A (AdDeltaE1ACR2) have been assayed as tumor cell specific lytic agents and shown to be effective in pancreatic tumors [137]. The gene discussed is DHTKD1; the disease is pancreatic neoplasm.